EFFECT OF HISTOCOMPATIBILITY FACTORS ON PULMONARY RETENTION OF INDIUM-111-LABELED GRANULOCYTES

被引:11
作者
DUTCHER, JP
RIGGS, C
FOX, JJ
JOHNSTON, GS
NORRIS, D
WIERNIK, PH
SCHIFFER, CA
机构
[1] UNIV MARYLAND,CTR CANC,DIV HEMATOL,BALTIMORE,MD 21201
[2] UNIV MARYLAND,CTR CANC,DEPT NUCL MED,BALTIMORE,MD 21201
关键词
alloimmunization; leukocyte scan; pulmonary infiltrates;
D O I
10.1002/ajh.2830330405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Granulocyte transfusions are associated with a number of side effects including febrile transfusion reactions and occasionally pulmonary infiltrates. There is evidence that the presence of preformed antibodies may be a cause of these complications. In this study, allogeneic 111lndium‐labeled granulocytes were used to evaluate the pulmonary retention of radioactivity in alloimmunized and non‐alloimmunized patients in an attempt to assess antibody effect on granulocyte migration. After injection of labeled allogeneic granulocytes into neutropenic patients, the ratios of lung to heart activity were calculated for the first 30 min of scanning. There was significantly greater retention of radioactivity from cells in the lungs of patients who were alloimmunized, having both lymphocytotoxic (anti‐HLA) and leukoagglutinating antibodies, compared to the activity in the lungs of non‐alloimmunized patients (P < 0.001) or of patients receiving autologous granulocytes (P < 0.001). This study demonstrates that labeled, mismatched granulocytes may be retained in the lungs for a significantly longer time in patients with preformed antibodies. This implies that transfusion of large numbers of such mismatched granulocytes, i. e., granulocyte transfusions, may also be retained in the lungs of alloimmunized patients, which could lead to pulmonary compromise. Therefore, granulocyte transfusions from random donors should not be given to alloimmunized patients. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:238 / 243
页数:6
相关论文
共 24 条
[1]  
APPLEBAUM FR, 1978, BLOOD, V52, P323
[2]  
CHOW HS, 1982, BLOOD, V59, P328
[3]   GRANULOCYTE TRANSFUSIONS AND OUTCOME OF ALLOIMMUNIZED PATIENTS WITH GRAM-NEGATIVE SEPSIS [J].
DAHLKE, MB ;
KEASHEN, M ;
ALAVI, JB ;
KOCH, PA ;
EISENSTAEDT, R .
TRANSFUSION, 1982, 22 (05) :374-378
[4]   PLATELET TRANSFUSION THERAPY - ONE-HOUR POST-TRANSFUSION INCREMENTS ARE VALUABLE IN PREDICTING THE NEED FOR HLA-MATCHED PREPARATIONS [J].
DALY, PA ;
SCHIFFER, CA ;
AISNER, J ;
WIERNIK, PH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (05) :435-438
[5]  
DUTCHER JP, 1983, BLOOD, V62, P354
[6]   RAPID MIGRATION OF INDIUM-111-LABELED GRANULOCYTES TO SITES OF INFECTION [J].
DUTCHER, JP ;
SCHIFFER, CA ;
JOHNSTON, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (10) :586-589
[7]   GRANULOCYTE TRANSFUSION THERAPY AND AMPHOTERICIN-B - ADVERSE REACTIONS [J].
DUTCHER, JP ;
KENDALL, J ;
NORRIS, D ;
SCHIFFER, C ;
AISNER, J ;
WIERNIK, PH .
AMERICAN JOURNAL OF HEMATOLOGY, 1989, 31 (02) :102-108
[8]  
Dutcher JP, 1990, MODERN TRANSFUSION T, P135
[9]   LEUKOCYTE TRANSFUSIONS - FUNCTION OF TRANSFUSED GRANULOCYTES FROM DONORS WITH CHRONIC MYELOCYTIC LEUKEMIA [J].
EYRE, HJ ;
GOLDSTEIN, IM ;
PERRY, S ;
GRAW, RG .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1970, 36 (04) :432-+
[10]   LEUKOCYTE TRANSFUSIONS - ROLE OF LEUKOCYTE ALLOANTIBODIES IN DETERMINING TRANSFUSION RESPONSE [J].
GOLDSTEIN, IM ;
EYRE, HJ ;
TERASAKI, PI ;
HENDERSON, ES ;
GRAW, RG .
TRANSFUSION, 1971, 11 (01) :19-+